chrisvoncsefalvay/vaers-outcomes huggingface dataset:
some sort of liquid coming out of her eyes periodically; face was swelling; swelling under her eyes; lips swelling; eyes were red; Initial information received on 31-Mar-2021 regarding an unsolicited valid non-serious case from a non health care professional in courtesy from Pfizer.  This case involves 82 years old female patient who experienced some sort of liquid coming out of her eyes periodically (eye discharge), face was swelling (face oedema), swelling under her eyes (periorbital swelling), lips swelling (lip swelling) and eyes were red (ocular hyperaemia), while receiving vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE [FLUZONE HIGH DOSE].  It was unknown if the patient had any medical history, concomitant disease or risk factor.   Medical treatment, vaccination, concomitant medication and family history were not provided.  In 2017, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  In 2017 the patient developed a non-serious some some sort of liquid coming out of her eyes periodically (eye discharge), face was swelling (face oedema), swelling under her eyes (periorbital swelling), lips swelling (lip swelling) and eyes were red (ocular hyperaemia), (unknown latency) following the administration of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE.  It was unknown if the patient experienced any additional symptoms/events.  It was also reported that PFIZER-BIONTECH VACCINE Question: Consumer stated she is 82 year old and interested in receiving the Pfizer-bioNTech COVID-1g (coronavirus diseaes) Vaccine; however, first she wants to compare the ingredients of this vaccine with the ingredients in Fluzone High- Dose, specifically the following: Sodium phosphate-buffered isotonic sodium chloride solution, Octylphenol ethoxylate, Formaldehyde. She repored: In 2017, received Fluzone High-Dose by Sanofi and had some kind of reaction, question have you heard of Oculorespiratory syndrome to the shot.  It was not reported if the patient received a corrective treatment for the events.  It was unknown if there were lab data/results available.  At the time of reporting, the outcome of events was reported as unknown.  There will be no information available on the batch number for this case.
Swelling began after 24 hours, sometime on Saturday.  Patient mainly felt fatigue in the afternoon and evening on Saturday, but started ice pack and took one tablet aleve 220mg Saturday. On Sunday the redness increased  up to a 4-5 inch diameter swollen reddened area.  From Sunday to Monday the red swollen area increased to about a 6 inch diameter area that covers the full middle area of her outer arm. Patient reports no fever, but the injection site is red and hot. Patient came to the pharmacy at 1pm Monday to discuss the reaction.   Patient says she took claritin yesterday and I suggested she switch to zyrtec today and continue cold compresses that she has been doing since Saturday and contact her doctor tomorrow if no improvement or worsening.
Patient received PENTACEL, PREVNAR and ROTATEQ. Cried immediately. Mom and grandmother took baby out to car in the carrier. Mom came back in abruptly and said that when she was putting the car seat in the child's eyes rolled back and she became limp. Did not jerk. Did not stop breathing as far as she knows but became unresponsive and would not respond immediately.
A little over 12hrs after vaccination experienced significant fever, chills, and body aches. Able to manage with acetaminophen PO.
I developed quite a sizable (2 inch diameter) swollen, red, raised area around the injection site which developed > 24 hours after the injection of the first dose of the vaccine. The site is painful to the touch and warm. No itching.  The injection itself was not traumatic.  I expect it to resolve but felt I should report it because it is such a new vaccine.
arm feels sore; arm does feel sore, heavy and it hurts; itchy; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy), PAIN IN EXTREMITY (arm feels sore) and MYALGIA (arm does feel sore, heavy and it hurts) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0071321A) for COVID-19 vaccination.     Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO), OMEPRAZOLE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 03-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-May-2021, the patient experienced PRURITUS (itchy). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm feels sore) and MYALGIA (arm does feel sore, heavy and it hurts). On 04-May-2021, PRURITUS (itchy) had resolved. At the time of the report, PAIN IN EXTREMITY (arm feels sore) and MYALGIA (arm does feel sore, heavy and it hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication includes Eldeberry Vitamin once a day and Vital Protein Hair Boost Vitamin 200mg once a day
Back pain; Hard time getting up; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Back pain) and SOMNOLENCE (Hard time getting up) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Back pain) and SOMNOLENCE (Hard time getting up). At the time of the report, BACK PAIN (Back pain) and SOMNOLENCE (Hard time getting up) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant  information was  provided. No Treatment information was  provided.
I was exposed to a person that tested positive for Covid 19 on March 17th.  I had my second vaccination on March 19th. I tested positive for Covid19 using a rapid test on March 27th.; I was exposed to a person that tested positive for Covid 19 on March 17th.  I had my second vaccination on March 19th. I tested positive for Covid19 using a rapid test on March 27th.; I was exposed to a person that tested positive for Covid 19 on March 17th.  I had my second vaccination on March 19th. I tested positive for Covid19 using a rapid test on March 27th.; This is a spontaneous report from contactable consumer female (patient) reported for herself. A 59-years-old female patient (non-pregnant) received first dose of bnt162b2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: E11283 or EI13S3 or E112S3, Expiration date: 01Apr2021), via an unspecified route of administration in left arm on 2Feb2021 08:45 AM at first dose, single for covid-19 immunisation. patient received second dose of bnt162b2 (PFIZ-ER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number: unknown, Expiration date: unknown), via an unspecified route of administration on 19March2021 at second dose, single for covid-19 immunisation. Patient had allergies to medications, food, or other products include Shrimp and Crab. Patient concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. patient received any other medications the patient received within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Facility where the most recent COVID-19 vaccine was administered at Hospital. Patient was exposed to a person that tested positive for Covid 19 on March 17th. she had second vaccination on March 19th. she tested positive for Covid19 using a rapid test on March 27th and event start date on 28Mar2021. Patient did not receive any treatment for the adverse event. patient underwent lab tests and procedures which included Nasal swab sars-cov-2 test: positive on 28March2021. The outcome of event was unknown.  No follow-up attempts are needed:  information about lot/batch number cannot be obtained.
When attaching a needle to syringe, the syringe snapped at the junction of the barrel and luer-lock end. The product was Tetanus-Diphtheria syringes LOT#U2287AA EXP: 02JUL09.
Diarrhea for 2 weeks with weight loss, blood in stool, eczema on face, neck & head. Blood immunology testing on 3/7/12 revealing egg & peanut allergy. With avoidance he is symptom free.
scratchy sore throat no swelling; Difficulty swallowing due to sore throat; Nausea; A spontaneous report was received from a healthcare professional concerning a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events nausea, scratchy sore throat no swelling, difficulty swallowing due to sore throat.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Feb 2021, prior to the onset of the events the patient received second of two planned doses of mRNA-1273 (lot/batch: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the event nausea, scratchy sore throat no swelling, difficulty swallowing due to sore throat.Practice Administrator did not provide any patient identifiers or contact information.Administrator was calling for her sister-in-law who was experiencing these symptoms. Vaccination was not given at their  clinic; did not have any other information. Told practice administrator to refer patient to HCP if symptoms continue or worsen. Administrator denied information in writing.Administrator does not want follow-up with Safety.  Treatment details included acetaminophen and ibuprofen.  Action taken with mRNA-1273 in response to the events was not applicable.   The outcome of events nausea, scratchy sore throat no swelling, difficulty swallowing due to sore throat was unknown.
daughter received 1st dose and contracted Strep; This is a spontaneous report from a Pfizer. A contactable consumer reported for a female patient (daughter) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and expiration date was not reported), first dose via an unspecified route of administration on 01Apr2021 single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date daughter of reporter received 1st dose (on unspecified date) and contracted Strep - after 21st day and he (Parent) scheduled 2nd is scheduled for Friday 23Apr2021. The mother of patient tried to get in touch with the health department in her area, but could not get in touch with anyone there - suggested that she contact her doctors office. The outcome of the event was unknown.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
after I gave the patient the flu shot, I noticed there was blood showing under the bandaid. I went to get cotton to give to the patient- when I got back , the patient told me she doesnot feel good and she was double over- I told her to take a deep breath and lean back. As she lean back, she fainted. I assist her in laying her down on the floor and asked my technician to call 911. The paramedics came and transport her to the hospital.
Client presented to clinic for 3rd injection today and reported that she experienced an episode of loss of consciousness 2 hours post vaccination after second dose of Rabies vaccine, while at school. Client stated that she did not have anything to eat prior to appointment and that she had to call her boyfriend to pick her up because she could not drive. 911 was not contacted.  She stated that she continued to feel light headed and experienced blurry vison for approximately 1 hour after incident.
I have had a sour taste in my mouth since receiving vaccine and I lost some sense of taste.  Everything I eat leaves a sour taste in my mouth that doesn't go away.  Its horrible.  ALSO my fingernails stopped growing (or very ver slowly)  and my systemic lymphedema is inflamed and more painful.  This happened since the first vaccine.  I also get sharp random pains in my body.    its been months since my vaccine and none of these  horrible side effects/symptoms have improved.
Felt sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was selected as an adult as per vaccine indication. The patient received Shingrix vaccine and felt sick. No further information reported.
Unresponsive for 1.5 hours, leg pain, refusal to walk.
1/4 - RECEIVED MODERNA VACCINE, PREGNANCY TEST CAME OUT NEGATIVE.  1/8 - PREGNANCY TEST CAME OUT POSITIVE 1/18 - HAD MISCARRIAGE, SAW TISSUE, NEGATIVE PREGNANCY HOME TEST, NEGATIVE HCT
red, itchy, round area at injection site; red, itchy, round area at injection site; red, itchy, round area at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (red, itchy, round area at injection site), VACCINATION SITE PRURITUS (red, itchy, round area at injection site) and VACCINATION SITE ERYTHEMA (red, itchy, round area at injection site) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included CLONAZEPAM for Anxiety, MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 07-Jan-2021 at 11:20 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021 at 10:20 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE REACTION (red, itchy, round area at injection site), VACCINATION SITE PRURITUS (red, itchy, round area at injection site) and VACCINATION SITE ERYTHEMA (red, itchy, round area at injection site). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Vaccination site pruritus, at an unspecified dose and frequency. On 08-Feb-2021, VACCINATION SITE REACTION (red, itchy, round area at injection site), VACCINATION SITE PRURITUS (red, itchy, round area at injection site) and VACCINATION SITE ERYTHEMA (red, itchy, round area at injection site) had resolved.            Action taken with mRNA-1273 in response to the event was not applicable.    This case was linked to US-MODERNATX, INC.-MOD-2021-015523 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-015523:First Dose
My healthy active 18 yr old son can barely walk. Inflammation of both legs, incredible pain. Diagnosed with Myositis, 100% sure this is related to the vaccine. There was no reason for a healthy 18 yr old to be forced to get a vaccine that he did not need other than his college mandating it in order to play sports. Now he may not even be able to play. He has Covid one year ago and was fine - his immune system fought the infection as it was designed to.
Within 4 hours, delevoped mild headache (same as with first dose). By 5am, feeling extremely achey, headache, nauseated, followed by dizziness.  Debilitating symptoms, unable to go to work due to the dizziness and stomach upset.
Vertigo with vomiting; Vertigo with vomiting; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo with vomiting) and VOMITING (Vertigo with vomiting) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 057MZHA) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer (Dose Number: 2 Batch (EL9265) and anatomical  location: Left Arm) on 08-Feb-2021, Pfizer (Dose Number: 1 Batch (EL3246) and anatomical location: Left arm) on 18-Jun-2021 and Pfizer (Dose Number: 3 Batch (EW0168) and anatomical  location: Left Arm) on 06-Aug-2021. Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Addison's disease, Hypothyroidism, Hypercholesterolemia, Type 2 diabetes mellitus and Allergy to antibiotic (Allergy to cipro). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) from 01-Feb-2015 to an unknown date, HYDROCORTISONE from 01-Feb-2015 to an unknown date, FLUDROCORTISONE from 01-Feb-2015 to an unknown date and ATORVASTATIN CALCIUM (LIPITOR) from 01-Feb-2015 to an unknown date for an unknown indication.    On 29-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-May-2022 at 11:00 PM, the patient experienced VERTIGO (Vertigo with vomiting) and VOMITING (Vertigo with vomiting). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 17-May-2022 to 21-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, VERTIGO (Vertigo with vomiting) and VOMITING (Vertigo with vomiting) was resolving.            Anatomical location for suspect product given as left leg.  Patient received motion sickness medication as a treatment medication for the adverse event Vertigo with vomiting.  Pfizer dose not have permission to contact about this report and does not have permission to contact the patient's healthcare provider.  The device date was 26-May-2022.
Also found a clot in my Left Leg.; developed bilateral PEs; This is a spontaneous report from a contactable consumer (patient herself) via Medical Information Team. A female patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 02Jun2021 as dose 2, single for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration as dose 1, single for COVID-19 immunization. Patient had her second Covid Vaccine on 02Jun2021. She did not know if this is coincidental, but she developed bilateral PEs on 15Jun2021. They also found a clot in her left Leg. The reported seriousness was non-serious. She was reaching out to us to see if anyone else had developed blood clots post vaccine. The outcome of the events was unknown.   Information about lot/batch number is requested.
Immediate within 5 seconds retching, burping, vomiting, itchiness, numbness sensation on the top of mouth,
I began losing weight unintentionally at first, started the week of the second vaccine. I also lost some weight right after the first vaccine but it had stopped. Then the weight started coming off again within days of getting the second vaccine.Then I began to lose my appetite and started having extreme fullness with very small amounts of food. I also developed nausea and abdominal pain. By July of 2021 I had lost 18 pounds. After numerous medical tests I was diagnosed with gastroparesis(a severe delay in gastric emptying). I had no prior GI issues before having the vaccine. I currently suffer with gastric pain, am unable to have a normal diet and have to take medication to help with my stomach emptying. There is still adelay in gastric emptying even with the medication. I also ahve bloating and distention. I had to take antibiotics for suspected SIBO.
J& J vaccine received 4/6/21  HISTORY OF PRESENT ILLNESS I have personally seen and examined the patient, reviewed all relevant labs, radiology studies, and chart notes and have discussed the assessment and plan in person with the interprofessional critical care team.  I have reviewed the critical care team note associated with today's encounter and agree with its contents with the following additions and exceptions:     Patient is a 53 yrs female admitted for acute hypoxemic respiratory failure secondary to COVID-19.  She has a past medical history significant for lupus(diagnosed at age 15) with lupus nephropathy status post renal transplant (in 1991, living donor) on immunosuppressive therapy, coronary artery disease, OSA on CPAP (last Sleep Medicine note from 2008 - CPAP 11 cmH2O), atrial fibrillation on chronic anticoagulation, CTEPH s/p pulmonary artery thromboendarterectomy, removal of right atrial thrombus and De Vega tricuspid annuloplasty in February 2008, and anal cell carcinoma status external beam post radiation therapy and chemotherapy.  Of note, she is vaccinated - she received the Johnson & Johnson vaccine on April 6.   Symptom onset was November 5th.  She tested positive for COVID on November 8th.  She was scheduled to get the monoclonal infusion today, but was found to be hypoxemic and transferred to the local ED. in the local ED, she was quite hypoxemic requiring 15 L non-rebreather which was then later escalated to BiPAP.  The last settings on BiPAP were 14/10 and FiO2 80%.  Tidal volumes on that was roughly 550 cc.  She was treated with remdesivir and dexamethasone.  She was transferred to our medical ICU for further management.   Upon arrival to the medical ICU, she was taking large tidal volumes on BiPAP 14/10. She was switched to CPAP 10 and was taking even higher volumes. She was placed back on BiPAP, now 12/8 80%. She was put on 100% with desaturations with minimal activity. Her RR is in the 30s.
Patient received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose from vials beyond 30-day use by date) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported. On 30-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose from vials beyond 30-day use by date). On 30-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received dose from vials beyond 30-day use by date) had resolved.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Date of refrigeration was reported as 19-Aug-2021. No concomitant medications were reported. No treatment drug details was reported.
New onset nasal herpes simplex coming up about 10-14 days after second Modera injection. Never had in life. No sexual activity for 3 years.
Itching started 3/13 started redness 3/14. 3/19/13 still red and itching.
Covid19 breakthrough.  1st vaccine received on 03/16/2021.  36 y/o PMH May-Thurner syndrome, stent placement and Sickle cell disease presented to ED with c/o abdominal pain and back pain x2 days.  CT A/P with nonspecific enteritis vs partial or intermittent small bowel obstruction.  Ordered transfer to medical center for GI consult.  Covid test +
Breakthrough case admission after 3 vaccines Moderna 2/25/21 Lot# 010A21A;  Moderna 3/25/21 Lot# 030A21A;  Moderna 10/29/21 Lot# 012F;
Since I had vaccine I developed a lump or several lump in my arm and my legs overate. 1 year a have abdominal pain and it has increased over the years.